For research use only
| Cat No. | ABC-TC0140 |
| Product Type | Mouse Melanoma Cell Lines |
| Cell Type | Epithelial |
| Species | Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Skin |
| Disease | Melanoma |
| Product Code | Cloudman S91 melanoma clone M-3; S91 clone M3; CLONE M3; M3 Clone M-3; Cloudman M3 |
Mouse (CxDBA)F1 melanoma. Established from a Cloudman S91 melanoma in a male mouse; The cells produce melanin.
Clone M‑3 is a murine melanoma cell line derived from a Cloudman S91 tumor that spontaneously arose in a DBA/2 mouse. These pigmented cells grow as adherent monolayers and exhibit epithelial-like morphology with strong melanin production, making them visually identifiable in culture. Clone M-3 is thus a valuable in vivo model for melanoma and immuno-oncology research. It expresses multiple melanoma-related markers, Pmel (gp100), and Tyr (tyrosinase), and also demonstrates ICAM-1 expression, which supports studies on tumor-immune interactions. These cells are highly tumorigenic in syngeneic DBA/2 mice upon subcutaneous or mammary fat pad implantation, with near-uniform tumor take rates. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from mycoplasma, fungi, yeast, and bacteria.
| Product Code | Cloudman S91 melanoma clone M-3; S91 clone M3; CLONE M3; M3 Clone M-3; Cloudman M3 |
| Species | Mouse |
| Cat.No | ABC-TC0140 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Skin |
| Disease | Melanoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Melanoma Cell Lines |
Clone M‑3 is an ideal syngeneic melanoma model for immuno-oncology and therapeutic efficacy studies, particularly for immune checkpoint inhibitors in DBA/2 mice. Its high tumorigenicity and pigmentation make it suitable for subcutaneous, mammary fat pad, and imaging-based tumor models. The line’s expression of melanoma differentiation antigens (tyrosinase, gp100, TRP-2) and MHC I supports tumor immunogenicity and immune profiling assays. Clone M‑3 also enables testing of EGFR-targeted therapies when engineered to express human EGFR, preserving tumor growth and receptor function in vivo. Its stable adherent phenotype supports in vitro drug screening, signal transduction analysis, and flow cytometry-based characterization.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).